Bank of Montreal
CODX

Bank of Montreal’s Co-Diagnostics CODX Stock Holding History

Bank of Montreal’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,497
Closed -$118K – 3935
2023
Q4 		$118K Buy
+2,497
New +$88K ﹤0.01% 3334
2022
Q4 		– Sell
-980
Closed -$96 – 4019
2022
Q3 		$96 Sell
980
-1,100
-53% -$154K ﹤0.01% 3478
2022
Q2 		$349 Buy
+2,080
New +$316K ﹤0.01% 2920
2021
Q2 		– Sell
-26
Closed -$7K – 3911
2021
Q1 		$7K Sell
26
-993
-97% -$396K ﹤0.01% 4504
2020
Q4 		$319K Buy
1,019
+978
+2,385% +$362K ﹤0.01% 2959
2020
Q3 		$18K Sell
41
-28
-41% -$14.4K ﹤0.01% 3878
2020
Q2 		$37K Buy
+69
New +$31.5K ﹤0.01% 3568
2019
Q3 		– Sell
-333
Closed -$8K – 4747
2019
Q2 		$8K Sell
333
-167
-33% -$4.67K ﹤0.01% 4593
2019
Q1 		$16K Buy
+500
New +$18K ﹤0.01% 3734

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of Montreal's CODX Position: Q1 2024 in Review

Bank of Montreal sold out of Co-Diagnostics (CODX) in Q1 2024, closing a stake of 2,497 shares — an estimated $118K sold.

Bank of Montreal first reported a position in CODX in Q1 2019 and held it in 9 quarters. The position peaked at $319K in Q4 2020. 38 funds tracked by Wall St. Rank hold CODX as of Q1 2024.

  • Bank of Montreal reported no remaining Co-Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 2,497 Co-Diagnostics shares in Q1 2024, an estimated $118K.
  • Bank of Montreal first reported a position in Co-Diagnostics in Q1 2019 and held it in 9 quarters.
  • Bank of Montreal's Co-Diagnostics position peaked at $319K in Q4 2020.
  • 38 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.